Brenno Pastò, Giulia Buzzatti, Clorinda Schettino, Umberto Malapelle, Alice Bergamini, Carmine De Angelis, Lucia Musacchio, Maria Vittoria Dieci, Elisabetta Kuhn, Matteo Lambertini, Anna Passarelli, Angela Toss, Alberto Farolfi, Rossana Roncato, Ettore Capoluongo, Riccardo Vida, Sandro Pignata, Maurizio Callari, Gustavo Baldassarre, Michele Bartoletti, Lorenzo Gerratana, Fabio Puglisi
The emerging era of precision medicine is characterized by an increasing availability of targeted anticancer therapies and by the parallel development of techniques to obtain more refined molecular data, whose interpretation may not always be straightforward. Molecular tumor boards gather various professional figures, in order to leverage the analysis of molecular data and provide prognostic and predictive insights for clinicians. In addition to healthcare development, they could also become a tool to promote knowledge and research spreading...
May 6, 2024: Critical Reviews in Oncology/hematology